Veflox

Veflox

levofloxacin

Manufacturer:

Community Pharm PCL

Distributor:

Community Pharm PCL
Concise Prescribing Info
Contents
Levofloxacin
Indications/Uses
Acute sinusitis & exacerbation of chronic bronchitis, community-acquired & nosocomial pneumonia, uncomplicated (mild to moderate) & complicated skin & skin structure infections, complicated UTI, chronic bacterial prostatitis, acute pyelonephritis. 750 mg: Empirical treatment for community-acquired pneumonia. In combination w/ other antimicrobial agent & PPI as triple therapy in patients w/ gastric ulcer caused by H. pylori infection & duodenal ulcer disease.
Dosage/Direction for Use
Acute sinusitis 500 mg once daily for 10-14 days or 750 mg once daily for 5 days. Acute exacerbation of chronic bronchitis 500 mg once daily for 7 days or 750 mg once daily for 5 days. Community-acquired pneumonia 500 mg once daily for 7-14 days or 750 mg once daily for 5 days. Complicated UTI, pyelonephritis 250 mg once daily for 10 days or 750 mg once daily for 5 days. Nosocomial pneumonia, complicated skin & skin structure infections 750 mg once daily for 7-14 days. Uncomplicated skin & skin structure infections 500 mg once daily for 7-10 days. Chronic bacterial prostatitis 500 mg once daily for 28 days. Uncomplicated UTI 250 mg once daily for 3 days. Renal impairment Acute sinusitis & exacerbation of chronic bronchitis, community-acquired pneumonia, uncomplicated skin & skin structure infections, chronic bacterial prostatitis CrCl 20-49 mL/min Initially 500 mg, then 250 mg once daily, 10-19 mL/min, hemodialysis or CAPD patients Initially 500 mg dose, then 250 mg every 48 hr. Complicated skin & skin structure infections, nosocomial pneumonia, community-acquired pneumonia CrCl 20-49 mL/min Initially 750 mg, then 750 mg every 48 hr, 10-19 mL/min, hemodialysis or CAPD patients Initially 750 mg dose, then 500 mg every 48 hr. Complicated UTI, acute pyelonephritis CrCl 10-19 mL/min Initially 250 mg, then 250 mg every 48 hr.
Administration
May be taken with or without food: Take at least 2 hr before or after antacids containing Mg or Al, metal cations (eg, Fe), sucralfate, multivit or dietary supplements containing Fe or Zn, or buffered didanosine.
Contraindications
Hypersensitivity to levofloxacin or other quinolones.
Special Precautions
Avoid treatment in patients w/ history of prolonged QT interval, uncorrected electrolyte disorders (eg, hypokalemia). Patients w/ known or suspected CNS disorders predisposing to seizures or lower seizure threshold (eg, severe cerebral arteriosclerosis, epilepsy). Avoid concomitant use w/ class IA (eg quinidine, procainamide) or class III (eg, amiodarone, sotalol) antiarrhythmic agents. Renal impairment. Pregnancy & lactation. 500 mg: Hypersensitivity. Discontinue use if skin rash, or muscle pain or tendon pain occurs. Diabetics. Patients w/ heart diseases especially arrhythmia & HTN. Phototoxicity or severe rash. Concomitant use w/ cisapride, erythromycin, antipsychotics drugs, TCAs; warfarin. Hepatic impairment. 750 mg: Avoid treatment in patients w/ history of tendon disorders or have experienced tendinitis or tendon rupture; peripheral neuropathy; w/ known history of myasthenia gravis. Symptoms of muscle weakness including resp difficulties.
Adverse Reactions
Diarrhea, nausea; dizziness, headache, insomnia. 500 mg: Chest pain, edema; fatigue, pain; rash, pruritus; constipation, abdominal pain, dyspepsia, vomiting; vaginitis; inj site reaction; pharyngitis, dyspnea; monilias. 750 mg: Erythema multiforme, SJS.
Drug Interactions
Prolonged QT interval w/ class IA (eg, quinidine, procainamide) or class III (eg, amiodarone, sotalol) antiarrhythmic agents. Decreased absorption w/ Al- or Mg-containing antacids; Fe or multivit or mineral supplements w/ Zn; sucralfate. Altered blood glucose conc & symptomatic hyperglycemia or hypoglycemia w/ antidiabetic agents (eg, insulin, glyburide). May increase risk of CNS stimulation & seizures w/ NSAIDs. Prolonged/increased prothrombin time w/ warfarin. 500 mg: May cause lower cerebral seizure threshold w/ theophylline, fenbufen or similar NSAIDs. Prolonged QT interval w/ cisapride, erythromycin, antipsychotics, TCAs. 750 mg: Increased t½ & decreased clearance of procainamide. Increased risk of severe tendon disorders (eg, tendinitis, tendon rupture) w/ corticosteroids in elderly >60 yr.
MIMS Class
Quinolones
ATC Classification
J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Presentation/Packing
Form
Veflox FC tab 500 mg
Packing/Price
1 × 10's
Form
Veflox FC tab 750 mg
Packing/Price
1 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in